FDA, COVID-19 and Vaccine
Digest more
The shift was a marked departure from previous FDA guidance, which recommended an annual COVID vaccine for everyone 6 months and older.
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.
2hon MSN
The FDA’s new approach to boosters could mean that kids will no longer be able to get vaccinated against the disease to begin with.
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.
The US Food and Drug Administration (FDA) announces new regulatory guidelines for future COVID-19 vaccines and booster shots. Moderna (MRNA) and Pfizer (PFE) shares move higher on this news, while Novavax (NVAX) takes a dip.
A change in recommending Covid vaccines for children and pregnant women would circumvent an expert panel but please many MAHA fans.